骨髓增生异常综合征治疗中的新药物 - Suppr

Suppr

超能文献

New agents in the treatment of MDS.

作者信息

List Alan F

机构信息

Malignant Hematology Division, H. Lee Moffitt Cancer Center and Research Institute, USA.

出版信息

Clin Adv Hematol Oncol. 2005 Nov;3(11):832-4.

PMID:16491623

Abstract

摘要

相似文献

New agents in the treatment of MDS.

Clin Adv Hematol Oncol. 2005 Nov;3(11):832-4.

New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide.

Exp Hematol. 2015 Aug;43(8):661-72. doi: 10.1016/j.exphem.2015.05.014. Epub 2015 Jun 27.

[Treatment of MDS].

Rinsho Ketsueki. 2014 Oct;55(10):1882-92.

Myelodysplastic syndromes (MDS).

Best Pract Res Clin Haematol. 2015 Mar;28(1):1-2. doi: 10.1016/j.beha.2014.11.007. Epub 2014 Nov 29.

Update on the pharmacotherapy for myelodysplastic syndromes.

Expert Opin Pharmacother. 2014 Sep;15(13):1811-25. doi: 10.1517/14656566.2014.937705. Epub 2014 Jul 31.

[Molecular target therapy for myelodysplastic syndrome].

Nihon Rinsho. 2012 Nov;70 Suppl 8:508-12.

Improving the outlook for myelodysplastic syndrome.

J Natl Cancer Inst. 2012 Aug 22;104(16):1204-6. doi: 10.1093/jnci/djs368. Epub 2012 Aug 16.

Evaluating new treatment options for MDS.

Clin Adv Hematol Oncol. 2007 Nov;5(11):1-9; quiz 10-2.

Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.

Clin Adv Hematol Oncol. 2008 Dec;6(12):1-15.

New agents in myelodysplastic syndromes.

Curr Hematol Rep. 2005 May;4(3):191-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New agents in the treatment of MDS.

Clin Adv Hematol Oncol. 2005 Nov;3(11):832-4.

New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide.

Exp Hematol. 2015 Aug;43(8):661-72. doi: 10.1016/j.exphem.2015.05.014. Epub 2015 Jun 27.

[Treatment of MDS].

Rinsho Ketsueki. 2014 Oct;55(10):1882-92.

Myelodysplastic syndromes (MDS).

Best Pract Res Clin Haematol. 2015 Mar;28(1):1-2. doi: 10.1016/j.beha.2014.11.007. Epub 2014 Nov 29.

Update on the pharmacotherapy for myelodysplastic syndromes.

Expert Opin Pharmacother. 2014 Sep;15(13):1811-25. doi: 10.1517/14656566.2014.937705. Epub 2014 Jul 31.

[Molecular target therapy for myelodysplastic syndrome].

Nihon Rinsho. 2012 Nov;70 Suppl 8:508-12.

Improving the outlook for myelodysplastic syndrome.

J Natl Cancer Inst. 2012 Aug 22;104(16):1204-6. doi: 10.1093/jnci/djs368. Epub 2012 Aug 16.

Evaluating new treatment options for MDS.

Clin Adv Hematol Oncol. 2007 Nov;5(11):1-9; quiz 10-2.

Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.

Clin Adv Hematol Oncol. 2008 Dec;6(12):1-15.

New agents in myelodysplastic syndromes.

Curr Hematol Rep. 2005 May;4(3):191-9.